STUDY of the geographical distribution of cancer has long been recognized to be one way of obtaining clues to its causation, and a great deal of work has been carried out to determine the incidence of different types of cancer in different parts of the world. Detailed (1966) .
Incidence data, however, constitute only part of the available evidence. Mortality statistics have been published for the principal types of cancer in fortyeight countries and in the urban areas of the fifteen Soviet republics (World Health Organization, 1966; Segi and Kurihara, 1964; Merkova, Tserkovnogo, and Kaufman, 1963) and, in some circumstances, these can provide useful indicators of incidence. Indeed, in some areas in which cancer registration is incomplete, mortality can provide a better indication of incidence than the official " incidence statistics ", particularly for cancers whose fatality is high or for which it is possible to obtain a reasonably accurate indication of the proportion that are not directly responsible for causing death.
Finally, there is an immense number of clinical and pathological records. Few can be used to provide reliable estimates of incidence, but, in exceptional circumstances, they provide a clear indication of a situation that is qualitatively different in different parts of the world (as with Burkitt's lymphoma and Kaposi's sarcoma).
The extent of the variation in cancer incidence has been reviewed and the geographical distribution of six types of cancer has been published in map form elsewhere (Doll, 1967 and 1968) . Corresponding numerical data and incidence rates for ten other types of cancer are given here. To allow for differences in the age distribution of different populations the tabulated rates have been standardized for age, using a rounded off variant of Segi's " world population " (Segi, 1960; International Union against Cancer, 1966) . Standardization does not, however, overcome the difficulty that cancer incidence varies with age in different ways in different countries nor, in particular, for the fact that in some populations the incidence of many cancers levels off or even falls in old age, whereas in other countries it continues to rise. This difference can be due to cohort effects produced by changes in the prevalence of carcinogenic factors with time or to other factors, such as the failure of old persons to make use of the medical services. Comparisons have, therefore, been limited to the age range 35 to 64 years, in which most cancers are relatively frequent, but which excludes data for the oldest ages that are least likely to reflect current conditions and are least likely to be accurate (Doll and Cook, 1967) .
To enable mortality rates to be used, conversion factors have been calculated from the data for eight countries that have published incidence and mortality rates over approximately the same periods (Chile, Denmark, Finland, Israel, New Zealand, Norway, Puerto Rico, and Sweden). These factors have been obtained by dividing the relevant truncated incidence rates* (standardized for age) by the corresponding mortality rates and averaging the result over the eight populations.
Estimates of cancer incidence in other countries have then been obtained by multiplying the site-specific mortality rates by the corresponding factors. Judged by the variability of the factors in the eight countries the error in the derived incidence rates is, for the most part, likely to be less than 20 per cent (47 out of 70 observations) but it could rise to 30 per cent (8 out of 70 observations), and the most extreme variations would be from -40 per cent to +68 per cent. For some countries mortality rates have been published only for ten-year age groups from 30 to 39 years of age rather than from 35 to 44 years of age. Other factors have, therefore, been derived from British experience, using the pooled mortality data for England and Wales over the ten years 1950 to 1959, to convert standardized mortality rates at ages 30 to 59 years into the corresponding rates at ages 35 to 64 years. Both sets of factors are shown in Table I . Table II gives incidence rates for fifteen types of primary cancer (13 in men and 2 in women) for thirty-four populations and for some of these cancers for a further forty-three populations. For thirty-three populations the standardized incidence rates have been derived from the age-specific rates given in the review volume published by the International Union against Cancer (1966) (Bombay Cancer Registry, 1966) and for Indian and African populations in Durban (Schonland and Bradshaw, 1968) . For forty-one populations the rates have been derived from the age-specific mortality statistics brought together by the World Health Organization (1966) , Segi and Kurihara (1964) and Merkova, Tserkovnogo, and Kaufman (1963) . These have been made comparable with the incidence rates by multiplying by conversion factors (Table I) and, in sixteen instances, by further conversion factors (Table I) to allow for the fact that the published rates related to ages 30 to 59 years. These also have been chosen to relate to periods close to or around 1961. Table III gives further data of particular interest for cancer of the oesophagus in three populations (Kmet, personal communication; Rose, 1967; and Skinner, 1967) and for cancer of the cervix uteri in four populations (Haenszel and Hillhouse, 1959) . Table IV gives incidence rates for primary cancer of the liver in forty-seven populations over the age range 15 to 44 years. For this type of cancer, comparisons are made at younger ages, partly because liver cancer appears early in adult life in areas where it is common and partly because there is less possibility of confusion between primary and secondary cancers than at older ages when gastric, colonic, bronchial, and gall bladder cancers are relatively frequent. Most of the rates (33) have been reported specifically for primary cancer of the liver, but 14 have been estimated from the recorded mortality for cancer of the liver and biliary passages or from incidence data that may include some other liver cancers. These last have been included because examination of the rates in six populations (Canada, Finland, Israel, New Zealand, Norway and Sweden) for which both the mortality from cancer of the liver and biliary passages and the incidence of primary liver cancer have been published, shows that, at ages 15 to 44 years, both sets of rates are practically identical. It will be noted that all the estimated rates, which may be regarded as maximal, are low.
All rates are shown for one sex only.* For comparison between countries this is usually unimportant, as the sex ratio of most cancers is relatively constant from one population to another. Cancer of the oesophagus-and to a less extent cancer of the lung and cancer of the larynx-provide exceptions. For cancer of the oesophagus the sex ratio at ages 35 to 64 years varies from less than 1-5 to 1 in England and Wales, Bombay, and Kazakhstan to 20 to 1 in France.
Further data that cannot be expressed in comparable arithmetrical form have also been collected in an extensive review of the subject by Dunham and Bailar (1968 I am grateful to Dr. P. Gregory for assistance in preparing the data for cancer of the liver, and to Miss J. Allen and Miss B. Hafner for much of the calculation.
